middle.news
Neurizon Secures Ethics Approval for NUZ-001 Oral Liquid Phase 1 Trial
9:42am on Wednesday 13th of May, 2026 AEST
•
Healthcare
Read Story
Neurizon Secures Ethics Approval for NUZ-001 Oral Liquid Phase 1 Trial
9:42am on Wednesday 13th of May, 2026 AEST
Key Points
Ethics approval granted by Bellberry HREC for Phase 1 oral liquid study
Trial to enrol 32 healthy volunteers assessing pharmacokinetics and safety
Oral liquid designed to improve administration flexibility for ALS patients
Study supports broader NUZ-001 clinical and regulatory development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurizon Therapeutics (ASX:NUZ)
OPEN ARTICLE